X4 Pharmaceuticals, Inc. (XFOR)
3.525
-0.10
(-2.62%)
USD |
NASDAQ |
Sep 16, 16:00
3.525
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Price : 3.525 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 3.60 | 3.64 | 3.31 | 3.62 | 2.081M |
| Sep 14, 2026 | 3.51 | 3.711 | 3.47 | 3.62 | 1.018M |
| Sep 11, 2026 | 3.44 | 3.55 | 3.24 | 3.50 | 1.253M |
| Sep 10, 2026 | 3.60 | 3.675 | 3.31 | 3.40 | 2.570M |
| Sep 09, 2026 | 3.50 | 3.67 | 3.45 | 3.60 | 1.402M |
| Sep 08, 2026 | 4.00 | 4.125 | 3.19 | 3.505 | 2.324M |
| Sep 04, 2026 | 4.01 | 4.08 | 4.00 | 4.04 | 168162.0 |
| Sep 03, 2026 | 4.06 | 4.069 | 3.99 | 4.04 | 409441.0 |
| Sep 02, 2026 | 4.10 | 4.17 | 4.015 | 4.04 | 360955.0 |
| Sep 01, 2026 | 3.97 | 4.11 | 3.97 | 4.07 | 203867.0 |
| Aug 31, 2026 | 4.02 | 4.10 | 4.00 | 4.04 | 245892.0 |
| Aug 28, 2026 | 4.22 | 4.23 | 4.00 | 4.04 | 356381.0 |
| Aug 27, 2026 | 4.18 | 4.39 | 4.145 | 4.23 | 597239.0 |
| Aug 26, 2026 | 4.16 | 4.23 | 4.075 | 4.17 | 707143.0 |
| Aug 25, 2026 | 4.05 | 4.18 | 3.995 | 4.16 | 390756.0 |
| Aug 24, 2026 | 4.03 | 4.095 | 3.94 | 4.05 | 299167.0 |
| Aug 21, 2026 | 4.05 | 4.175 | 4.005 | 4.04 | 1.220M |
| Aug 20, 2026 | 4.12 | 4.22 | 3.99 | 4.03 | 561211.0 |
| Aug 19, 2026 | 4.25 | 4.35 | 4.14 | 4.16 | 406049.0 |
| Aug 18, 2026 | 4.27 | 4.32 | 4.145 | 4.21 | 362085.0 |
| Aug 17, 2026 | 4.20 | 4.335 | 4.13 | 4.30 | 1.095M |
| Aug 14, 2026 | 4.26 | 4.33 | 4.05 | 4.22 | 840932.0 |
| Aug 13, 2026 | 4.28 | 4.455 | 4.19 | 4.29 | 1.128M |
| Aug 12, 2026 | 4.29 | 4.55 | 4.245 | 4.29 | 1.041M |
| Aug 11, 2026 | 4.19 | 4.425 | 4.13 | 4.28 | 1.080M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sarepta Therapeutics, Inc. | 19.75 |
| Arrowhead Pharmaceuticals, Inc. | 65.80 |
| Oncolytics Biotech, Inc. | 0.7784 |
| Sangamo Therapeutics, Inc. | 0.1473 |
| Anixa Biosciences, Inc. | 2.59 |
Price Related Metrics
| PS Ratio | 22.60 |
| Price to Book Value | 2.179 |
| Earnings Yield | -33.86% |
| Market Cap | 338.80M |